Sarocladium implicatum: an unusual agent of opportunistic infection in a COVID-19 patient

Authors

  • Gilberto Gambero Gaspar Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Medicina Social, Ribeirão Preto, São Paulo, Brazil https://orcid.org/0000-0002-6804-454X
  • Ludmilla Tonani Universidade de São Paulo, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Ribeirão Preto, São Paulo, Brazil https://orcid.org/0000-0001-6892-8962
  • Patrícia Helena Grizante Barião Universidade de São Paulo, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Ribeirão Preto, São Paulo, Brazil https://orcid.org/0000-0003-1335-3975
  • Otávio Guilherme Gonçalves de Almeida Universidade de São Paulo, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Ribeirão Preto, São Paulo, Brazil https://orcid.org/0000-0002-9271-1752
  • Roberto Martinez Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Clínica Médica, Ribeirão Preto, São Paulo, Brazil https://orcid.org/0000-0001-6906-7981
  • Marcia Regina von Zeska Kress Universidade de São Paulo, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Ribeirão Preto, São Paulo, Brazil https://orcid.org/0000-0003-1239-7722

DOI:

https://doi.org/10.1590/S1678-9946202567075

Keywords:

Sarocladium implicatum, Immunocompromised, COVID-19, Hyalohyphomycosis

Abstract

Sarocladium spp. are filamentous fungi commonly associated with plant diseases and only rarely cause hyalohyphomycosis in humans. Immunosuppressed patients are at risk for this infection, which typically presents with skin and subcutaneous lesions that may eventually disseminate to internal organs. This study reports a case of a man in intensive care following SARS-CoV-2 infection. During hospitalization, he developed neutropenia, persistent fever, and a cavitary lung lesion. Sarocladium spp. was isolated from blood cultures, and the patient was treated with voriconazole, leading to a successful cure. To our knowledge, this is the first reported case of Sarocladium implicatum infection in a COVID-19 patient, underscoring the importance of monitoring opportunistic fungal infections in immunocompromised individuals, particularly during epidemics and pandemics.

Downloads

Download data is not yet available.

Downloads

Published

2025-11-17

Issue

Section

Case Report

How to Cite

Gaspar, G. G., Tonani, L., Barião, P. H. G., Almeida, O. G. G. de, Martinez, R., & Kress, M. R. von Z. (2025). Sarocladium implicatum: an unusual agent of opportunistic infection in a COVID-19 patient. Revista Do Instituto De Medicina Tropical De São Paulo, 67, e75. https://doi.org/10.1590/S1678-9946202567075